REGENERON PHARMACEUTICALS, INC. (REGN) Total assets 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) total assets at each fiscal year-end, per SEC filings.
$40.6BFY2025 · since FY2016: $7.0B → $40.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40.6B | +7.4% |
| FY2024 | $37.8B | +14.1% |
| FY2023 | $33.1B | +13.2% |
| FY2022 | $29.2B | +14.9% |
| FY2021 | $25.4B | +48.2% |
| FY2020 | $17.2B | +15.9% |
| FY2019 | $14.8B | +26.2% |
| FY2018 | $11.7B | +33.9% |
| FY2017 | $8.8B | +25.7% |
| FY2016 | $7.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice